Everyone likes to claim they offer fast turnaround times, but clients often come to KCAS having been burned by the lack of timeliness on their Discovery projects.
The paradigm of drug development outsourcing is in a period of rapid transition coupled with a growing market in a competitive space.
Animal health programs have consistently been supported by KCAS with increasing study complexities although they have constituted a small percentage of the overall pharmaceutical development,
The bioanalytical landscape for support of biopharmaceuticals (biologics or large molecules) and biomarker testing is an ever changing map.
Protein characterization is a broad term describing the profile or fingerprint of a large molecule’s (or biologic’s) physical,
If you’re running a clinical or preclinical study, there are many components that you need to think about,